What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Prescription Drugs

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1882975

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1882975

Fluoroquinolones Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

PUBLISHED: October 20, 2025

PAGES: 186 Pages

DELIVERY TIME: Inquiry

ADD TO COMPARE

SELECT AN OPTION

The global fluoroquinolones market continues to expand due to the rising global burden of bacterial infections and the growing need for effective broad-spectrum antibiotics. According to the latest report, the market reached USD 4.62 billion in 2024, is expected to grow to USD 4.83 billion in 2025, and will rise further to USD 6.91 billion by 2032, registering a CAGR of 5.2% during the forecast period. In 2024, North America dominated the market with a 46.32% share, driven by strong antibiotic usage, established healthcare infrastructure, and early adoption of novel formulations.

Fluoroquinolones are broad-spectrum antibiotics effective against both gram-positive and gram-negative pathogens, particularly Pseudomonas aeruginosa. Their excellent oral absorption, high tissue penetration, and wide therapeutic applications make them vital drugs for treating urinary tract infections, respiratory infections, skin infections, and ENT-related bacterial diseases. The WHO reported in 2023 that South Africa recorded a tuberculosis incidence rate of 468 per 100,000 people, illustrating the global need for effective antibiotics and supporting the demand for fluoroquinolones.

Market Dynamics

Market Drivers

The growing prevalence of bacterial infections such as UTIs, respiratory diseases, and skin infections remains the primary factor propelling market growth. In 2022, the American Lung Association reported that 11.7 million people in the U.S. had COPD, highlighting the heavy burden of respiratory conditions that frequently require antibiotic therapy. Hospital-acquired infections and increased surgical interventions further elevate the need for effective and fast-acting fluoroquinolone drugs.

Market Restraints

Despite their effectiveness, fluoroquinolones face challenges due to severe side effects involving the nervous system, tendons, muscles, and joints. According to the U.K. MHRA (January 2024), 1 to 10 people per 10,000 users may develop long-term or permanent disabilities caused by adverse effects. These risks have led to stronger regulatory warnings, reduced prescriptions, and a shift toward safer alternatives, mildly restraining global market expansion.

Market Opportunities

Fluoroquinolones are now being explored beyond traditional antibiotic uses, particularly for anti-cancer applications. Research from the Medical University of Silesia (July 2024) reported that modifying fluoroquinolone structures and combining them with metal ions significantly improves their anticancer activity. Such repurposing creates new revenue streams for pharmaceutical companies and expands future clinical applications.

Market Challenges

Antimicrobial resistance continues to be a major obstacle, limiting the real-world effectiveness of fluoroquinolones. The JAC-Antimicrobial Resistance report (August 2024) found 15-25% resistance rates in Pseudomonas aeruginosa, reducing the clinical utility of these antibiotics. Healthcare systems are adopting strict stewardship programs to manage resistance trends and optimize antibiotic use.

Key Market Trends

Antimicrobial Stewardship Programs (ASPs) have emerged as a crucial trend to ensure safe and optimal use of fluoroquinolones. A November 2022 NIH report demonstrated a 57% improvement in P. aeruginosa and 15% improvement in E. coli susceptibility after 10 years of ASP implementation. These initiatives significantly extend drug lifespan and enhance treatment outcomes.

Segmentation Insights

By Generation

The third-generation fluoroquinolones held the largest market share in 2024, supported by product launches such as ANI Pharmaceuticals' generic Levofloxacin Oral Solution.

The fourth-generation segment is projected to grow fastest due to improved gram-positive and anaerobic coverage.

By Application

Respiratory infections dominated in 2024, driven by rising global TB cases-10.8 million cases in 2023, as per WHO.

The urinary tract infections segment also showed significant growth due to high UTI prevalence, especially among women.

By Route of Administration

The oral segment led the market owing to convenience and strong absorption characteristics.

Parenteral fluoroquinolones remain essential for severe infections requiring rapid action.

By Distribution Channel

Retail pharmacies held the dominant share in 2024, with a U.S. outpatient prescription rate of 44 per 1,000 population. Online pharmacies are growing rapidly due to affordability and accessibility.

Regional Outlook

North America led the market, reaching USD 2.14 billion in 2024. The U.S. remains the major contributor due to high infectious disease prevalence and strong stewardship policies.

Europe ranked second, supported by technological advancements and expanded antibiotic manufacturing.

Asia-Pacific is the fastest-growing region, responsible for 45% of global TB cases in 2023, driving demand for effective antimicrobials.

Latin America and Middle East & Africa will grow moderately with rising healthcare access and generic drug availability.

Conclusion

With the market rising from USD 4.62 billion in 2024 to USD 6.91 billion by 2032, fluoroquinolones will remain essential in global infectious disease management. Continued product launches, expanding clinical applications, and strong regional demand will support long-term market growth.

Segmentation By Generation

First Generation
Second Generation
Third Generation
Fourth Generation

By Application

Skin Infections
Respiratory Infections
Urinary Tract Infections
Others

By Route of Administration

Oral
Parenteral
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region

North America (By Generation, Application, Route of Administration, Distribution Channel, and Country)
- U.S.
- Canada
Europe (By Generation, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
Asia Pacific (By Generation, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
Latin America (By Generation, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa (By Generation, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
- GCC
- South Africa
Rest of the Middle East & Africa

Product Code: FBI113751

Table of Content

1. Introduction

1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends

4. Key Insights

4.1. Pipeline Analysis, By Key Players
4.2. Prevalence of Key Diseases, By Key Countries/Regions, 2024
4.3. Overview of Antimicrobial Treatment Guidelines
4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Fluoroquinolones Market Analysis, Insights and Forecast, 2019-2032

5.1. Market Analysis, Insights and Forecast - By Generation
- 5.1.1. First Generation
- 5.1.2. Second Generation
- 5.1.3. Third Generation
- 5.1.4. Fourth Generation
5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Skin Infections
- 5.2.2. Respiratory Infections
- 5.2.3. Urinary Tract Infections
- 5.2.4. Others
5.3. Market Analysis, Insights and Forecast - By Route of Administration
- 5.3.1. Oral
- 5.3.2. Parenteral
- 5.3.3. Others
5.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.4.1. Hospital Pharmacy
- 5.4.2. Retail Pharmacy
- 5.4.3. Online Pharmacy
5.5. Market Analysis, Insights and Forecast - Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa

6. North America Fluoroquinolones Market Analysis, Insights and Forecast, 2019-2032

6.1. Market Analysis, Insights and Forecast - By Generation
- 6.1.1. First Generation
- 6.1.2. Second Generation
- 6.1.3. Third Generation
- 6.1.4. Fourth Generation
6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Skin Infections
- 6.2.2. Respiratory Infections
- 6.2.3. Urinary Tract Infections
- 6.2.4. Others
6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Others
6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1. Hospital Pharmacy
- 6.4.2. Retail Pharmacy
- 6.4.3. Online Pharmacy
6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada

7. Europe Fluoroquinolones Market Analysis, Insights and Forecast, 2019-2032

7.1. Market Analysis, Insights and Forecast - By Generation
- 7.1.1. First Generation
- 7.1.2. Second Generation
- 7.1.3. Third Generation
- 7.1.4. Fourth Generation
7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Skin Infections
- 7.2.2. Respiratory Infections
- 7.2.3. Urinary Tract Infections
- 7.2.4. Others
7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1. Oral
- 7.3.2. Parenteral
- 7.3.3. Others
7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1. Hospital Pharmacy
- 7.4.2. Retail Pharmacy
- 7.4.3. Online Pharmacy
7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.5.1. Germany
- 7.5.2. U.K.
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe

8. Asia Pacific Fluoroquinolones Market Analysis, Insights and Forecast, 2019-2032

8.1. Market Analysis, Insights and Forecast - By Generation
- 8.1.1. First Generation
- 8.1.2. Second Generation
- 8.1.3. Third Generation
- 8.1.4. Fourth Generation
8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Skin Infections
- 8.2.2. Respiratory Infections
- 8.2.3. Urinary Tract Infections
- 8.2.4. Others
8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1. Oral
- 8.3.2. Parenteral
- 8.3.3. Others
8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1. Hospital Pharmacy
- 8.4.2. Retail Pharmacy
- 8.4.3. Online Pharmacy
8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.5.1. China
- 8.5.2. Japan
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific

9. Latin America Fluoroquinolones Market Analysis, Insights and Forecast, 2019-2032

9.1. Market Analysis, Insights and Forecast - By Generation
- 9.1.1. First Generation
- 9.1.2. Second Generation
- 9.1.3. Third Generation
- 9.1.4. Fourth Generation
9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Skin Infections
- 9.2.2. Respiratory Infections
- 9.2.3. Urinary Tract Infections
- 9.2.4. Others
9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1. Oral
- 9.3.2. Parenteral
- 9.3.3. Others
9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1. Hospital Pharmacy
- 9.4.2. Retail Pharmacy
- 9.4.3. Online Pharmacy
9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America

10. Middle East & Africa Fluoroquinolones Market Analysis, Insights and Forecast, 2019-2032

10.1. Market Analysis, Insights and Forecast - By Generation
- 10.1.1. First Generation
- 10.1.2. Second Generation
- 10.1.3. Third Generation
- 10.1.4. Fourth Generation
10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Skin Infections
- 10.2.2. Respiratory Infections
- 10.2.3. Urinary Tract Infections
- 10.2.4. Others
10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1. Oral
- 10.3.2. Parenteral
- 10.3.3. Others
10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1. Hospital Pharmacy
- 10.4.2. Retail Pharmacy
- 10.4.3. Online Pharmacy
10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

11.1. Global Market Share Analysis (2024)
11.2. Company Profiles
- 11.2.1. Pfizer Inc
  - 11.2.1.1. Overview
  - 11.2.1.2. Applications
  - 11.2.1.3. SWOT Analysis
  - 11.2.1.4. Recent Developments
  - 11.2.1.5. Strategies
  - 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Astellas Pharma Inc.
  - 11.2.2.1. Overview
  - 11.2.2.2. Applications
  - 11.2.2.3. SWOT Analysis
  - 11.2.2.4. Recent Developments
  - 11.2.2.5. Strategies
  - 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Bayer AG
  - 11.2.3.1. Overview
  - 11.2.3.2. Applications
  - 11.2.3.3. SWOT Analysis
  - 11.2.3.4. Recent Developments
  - 11.2.3.5. Strategies
  - 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Abbott
  - 11.2.4.1. Overview
  - 11.2.4.2. Applications
  - 11.2.4.3. SWOT Analysis
  - 11.2.4.4. Recent Developments
  - 11.2.4.5. Strategies
  - 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Sandoz Group AG
  - 11.2.5.1. Overview
  - 11.2.5.2. Applications
  - 11.2.5.3. SWOT Analysis
  - 11.2.5.4. Recent Developments
  - 11.2.5.5. Strategies
  - 11.2.5.6. Financials (Based on Availability)
- 11.2.6. AbbVie Inc.
  - 11.2.6.1. Overview
  - 11.2.6.2. Applications
  - 11.2.6.3. SWOT Analysis
  - 11.2.6.4. Recent Developments
  - 11.2.6.5. Strategies
  - 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Bristol-Myers Squibb Company
  - 11.2.7.1. Overview
  - 11.2.7.2. Applications
  - 11.2.7.3. SWOT Analysis
  - 11.2.7.4. Recent Developments
  - 11.2.7.5. Strategies
  - 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Merck & Co., Inc.
  - 11.2.8.1. Overview
  - 11.2.8.2. Applications
  - 11.2.8.3. SWOT Analysis
  - 11.2.8.4. Recent Developments
  - 11.2.8.5. Strategies
  - 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
  - 11.2.9.1. Overview
  - 11.2.9.2. Applications
  - 11.2.9.3. SWOT Analysis
  - 11.2.9.4. Recent Developments
  - 11.2.9.5. Strategies
  - 11.2.9.6. Financials (Based on Availability)

Product Code: FBI113751

List of Tables

Table 1: Global Fluoroquinolones Market Revenue (USD billion) Forecast, By Generation, 2019-2032
Table 2: Global Fluoroquinolones Market Revenue (USD billion) Forecast, By Application, 2019-2032
Table 3: Global Fluoroquinolones Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032
Table 4: Global Fluoroquinolones Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032
Table 5: Global Fluoroquinolones Market Revenue (USD billion) Forecast, By Region, 2019-2032
Table 6: North America Fluoroquinolones Market Revenue (USD billion) Forecast, By Generation, 2019-2032
Table 7: North America Fluoroquinolones Market Revenue (USD billion) Forecast, By Application, 2019-2032
Table 8: North America Fluoroquinolones Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032
Table 9: North America Fluoroquinolones Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032
Table 10: North America Fluoroquinolones Market Revenue (USD billion) Forecast, By Country, 2019-2032
Table 11: Europe Fluoroquinolones Market Revenue (USD billion) Forecast, By Generation, 2019-2032
Table 12: Europe Fluoroquinolones Market Revenue (USD billion) Forecast, By Application, 2019-2032
Table 13: Europe Fluoroquinolones Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032
Table 14: Europe Fluoroquinolones Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032
Table 15: Europe Fluoroquinolones Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
Table 16: Asia Pacific Fluoroquinolones Market Revenue (USD billion) Forecast, By Generation, 2019-2032
Table 17: Asia Pacific Fluoroquinolones Market Revenue (USD billion) Forecast, By Application, 2019-2032
Table 18: Asia Pacific Fluoroquinolones Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032
Table 19: Asia Pacific Fluoroquinolones Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032
Table 20: Asia Pacific Fluoroquinolones Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
Table 21: Latin America Fluoroquinolones Market Revenue (USD billion) Forecast, By Generation, 2019-2032
Table 22: Latin America Fluoroquinolones Market Revenue (USD billion) Forecast, By Application, 2019-2032
Table 23: Latin America Fluoroquinolones Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032
Table 24: Latin America Fluoroquinolones Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032
Table 25: Latin America Fluoroquinolones Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
Table 26: Middle East & Africa Fluoroquinolones Market Revenue (USD billion) Forecast, By Generation, 2019-2032
Table 27: Middle East & Africa Fluoroquinolones Market Revenue (USD billion) Forecast, By Application, 2019-2032
Table 28: Middle East & Africa Fluoroquinolones Market Revenue (USD billion) Forecast, By Route of Administration, 2019-2032
Table 29: Middle East & Africa Fluoroquinolones Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032
Table 30: Middle East & Africa Fluoroquinolones Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

Figure 1: Global Fluoroquinolones Market Revenue Breakdown (USD billion, %) By Region, 2024 & 2032
Figure 2: Global Fluoroquinolones Market Value Share (%), By Generation, 2024 & 2032
Figure 3: Global Fluoroquinolones Market Value Share (%), By Application, 2024 & 2032
Figure 4: Global Fluoroquinolones Market Value Share (%), By Route of Administration, 2024 & 2032
Figure 5: Global Fluoroquinolones Market Value Share (%), By Distribution Channel, 2024 & 2032
Figure 6: Global Fluoroquinolones Market Value Share (%), By Region, 2024 & 2032
Figure 7: North America Fluoroquinolones Market Value (USD billion), By Generation, 2024 & 2032
Figure 8: North America Fluoroquinolones Market Value Share (%), By Generation, 2024
Figure 9: North America Fluoroquinolones Market Value (USD billion), By Application, 2024 & 2032
Figure 10: North America Fluoroquinolones Market Value Share (%), By Application, 2024
Figure 11: North America Fluoroquinolones Market Value (USD billion), By Route of Administration, 2024 & 2032
Figure 12: North America Fluoroquinolones Market Value Share (%), By Route of Administration, 2024
Figure 13: North America Fluoroquinolones Market Value (USD billion), By Distribution Channel, 2024 & 2032
Figure 14: North America Fluoroquinolones Market Value Share (%), By Distribution Channel, 2024
Figure 15: North America Fluoroquinolones Market Value (USD billion), By Country, 2024 & 2032
Figure 16: North America Fluoroquinolones Market Value Share (%), By Country, 2024
Figure 17: Europe Fluoroquinolones Market Value (USD billion), By Generation, 2024 & 2032
Figure 18: Europe Fluoroquinolones Market Value Share (%), By Generation, 2024
Figure 19: Europe Fluoroquinolones Market Value (USD billion), By Application, 2024 & 2032
Figure 20: Europe Fluoroquinolones Market Value Share (%), By Application, 2024
Figure 21: Europe Fluoroquinolones Market Value (USD billion), By Route of Administration, 2024 & 2032
Figure 22: Europe Fluoroquinolones Market Value Share (%), By Route of Administration, 2024
Figure 23: Europe Fluoroquinolones Market Value (USD billion), By Distribution Channel, 2024 & 2032
Figure 24: Europe Fluoroquinolones Market Value Share (%), By Distribution Channel, 2024
Figure 25: Europe Fluoroquinolones Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
Figure 26: Europe Fluoroquinolones Market Value Share (%), By Country/ Sub-region, 2024
Figure 27: Asia Pacific Fluoroquinolones Market Value (USD billion), By Generation, 2024 & 2032
Figure 28: Asia Pacific Fluoroquinolones Market Value Share (%), By Generation, 2024
Figure 29: Asia Pacific Fluoroquinolones Market Value (USD billion), By Application, 2024 & 2032
Figure 30: Asia Pacific Fluoroquinolones Market Value Share (%), By Application, 2024
Figure 31: Asia Pacific Fluoroquinolones Market Value (USD billion), By Route of Administration, 2024 & 2032
Figure 32: Asia Pacific Fluoroquinolones Market Value Share (%), By Route of Administration, 2024
Figure 33: Asia Pacific Fluoroquinolones Market Value (USD billion), By Distribution Channel, 2024 & 2032
Figure 34: Asia Pacific Fluoroquinolones Market Value Share (%), By Distribution Channel, 2024
Figure 35: Asia Pacific Fluoroquinolones Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
Figure 36: Asia Pacific Fluoroquinolones Market Value Share (%), By Country/ Sub-region, 2024
Figure 37: Latin America Fluoroquinolones Market Value (USD billion), By Generation, 2024 & 2032
Figure 38: Latin America Fluoroquinolones Market Value Share (%), By Generation, 2024
Figure 39: Latin America Fluoroquinolones Market Value (USD billion), By Application, 2024 & 2032
Figure 40: Latin America Fluoroquinolones Market Value Share (%), By Application, 2024
Figure 41: Latin America Fluoroquinolones Market Value (USD billion), By Route of Administration, 2024 & 2032
Figure 42: Latin America Fluoroquinolones Market Value Share (%), By Route of Administration, 2024
Figure 43: Latin America Fluoroquinolones Market Value (USD billion), By Distribution Channel, 2024 & 2032
Figure 44: Latin America Fluoroquinolones Market Value Share (%), By Distribution Channel, 2024
Figure 45: Latin America Fluoroquinolones Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
Figure 46: Latin America Fluoroquinolones Market Value Share (%), By Country/ Sub-region, 2024
Figure 47: Middle East & Africa Fluoroquinolones Market Value (USD billion), By Generation, 2024 & 2032
Figure 48: Middle East & Africa Fluoroquinolones Market Value Share (%), By Generation, 2024
Figure 49: Middle East & Africa Fluoroquinolones Market Value (USD billion), By Application, 2024 & 2032
Figure 50: Middle East & Africa Fluoroquinolones Market Value Share (%), By Application, 2024
Figure 51: Middle East & Africa Fluoroquinolones Market Value (USD billion), By Route of Administration, 2024 & 2032
Figure 52: Middle East & Africa Fluoroquinolones Market Value Share (%), By Route of Administration, 2024
Figure 53: Middle East & Africa Fluoroquinolones Market Value (USD billion), By Distribution Channel, 2024 & 2032
Figure 54: Middle East & Africa Fluoroquinolones Market Value Share (%), By Distribution Channel, 2024
Figure 55: Middle East & Africa Fluoroquinolones Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
Figure 56: Middle East & Africa Fluoroquinolones Market Value Share (%), By Country/ Sub-region, 2024
Figure 57: Global Fluoroquinolones Market Share (%), By Company, 2024